Dolutegravir-based regimen maintains virological success in a patient with archived mutations to integrase inhibitors

AIDS. 2017 Aug 24;31(13):1900-1901. doi: 10.1097/QAD.0000000000001581.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Drug Resistance, Viral
  • HIV Infections / drug therapy
  • HIV Infections / virology*
  • HIV Integrase / genetics*
  • HIV Integrase Inhibitors / administration & dosage*
  • HIV-1 / enzymology*
  • HIV-1 / isolation & purification
  • Heterocyclic Compounds, 3-Ring / administration & dosage*
  • Humans
  • Male
  • Middle Aged
  • Mutation, Missense*
  • Oxazines
  • Piperazines
  • Pyridones
  • Sustained Virologic Response*
  • Treatment Outcome

Substances

  • HIV Integrase Inhibitors
  • Heterocyclic Compounds, 3-Ring
  • Oxazines
  • Piperazines
  • Pyridones
  • dolutegravir
  • HIV Integrase